CLINICAL TRIALS PROFILE FOR SINGULAIR
✉ Email this page to a colleague
All Clinical Trials for SINGULAIR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00115297 ↗ | Montelukast for Early Life Wheezing | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2/Phase 3 | 2004-09-01 | This study will determine the effects of montelukast on the duration of wheezing in children 12 months to 3 years of age who visit a physician for care of a wheezing illness. Only patients from the Ankara area of Hacettepe University Medical Center in Turkey will be included in this study. |
NCT00115297 ↗ | Montelukast for Early Life Wheezing | Completed | University of Massachusetts, Worcester | Phase 2/Phase 3 | 2004-09-01 | This study will determine the effects of montelukast on the duration of wheezing in children 12 months to 3 years of age who visit a physician for care of a wheezing illness. Only patients from the Ankara area of Hacettepe University Medical Center in Turkey will be included in this study. |
NCT00119015 ↗ | The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis | Terminated | Merck Sharp & Dohme Corp. | Phase 4 | 2005-07-01 | Some people with nasal allergy symptoms continue to have symptoms even after treatment with a nasal steroid spray. The purpose of this study is to see if these patients are helped by adding another medication (montelukast) to their treatment compared to placebo (a substance that looks like the active medication but does not contain the drug). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SINGULAIR
Condition Name
Clinical Trial Locations for SINGULAIR
Trials by Country
Clinical Trial Progress for SINGULAIR
Clinical Trial Phase
Clinical Trial Sponsors for SINGULAIR
Sponsor Name